| |
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
TOBRADEX® Ophthalmic Suspension(tobramycin 0.3 and dexamethasone 0.1 sterile ophthalmic suspension and ointment) has been the most frequently prescribed anti-infective and anti-inflammatory combination drug on the market for 20 years. TOBRADEX® suspension is used to treat eye inflammation where infection or the risk of infection is present.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Aminoglycosides are used for serious gram-negative infections, especially Pseudomonas aeruginosa. They are active against most gram-negative aerobic bacilli but lack activity against anaerobes and most gram-positive bacteria, except for most staphylococci; however, some gram-negative bacilli and methicillin-resistant staphylococci are resistant.
|
Company:
Date:
April 16, 2009
|
|
|
|
|
|
|
|
|
|
Zylet® is a unique, combination ophthalmic suspension product that combines the proven anti-inflammatory power of loteprednol etabonate, with the broad-spectrum anti-infective agent, tobramycin. Zylet is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. Zylet® is the first FDA approved anti-inflammatory/
|
Company:
Date:
April 16, 2009
|
|
|
|
|